Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Current Medical Research and Opinion|January 16, 2008
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetesItamar Raz, Yu Chen, Mei Wu, et al.
European Journal of Clinical Pharmacology|April 25, 2012
Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairmentPaul Statkevich, Teddy Kosoglou, Richard A Preston, et al.
Biochemical Society Transactions|May 17, 2008
The use of Affymetrix GeneChips as a tool for studying alternative forms of RNAAndrew P Harrison, Joanna Rowsell, Renata da Silva Camargo, et al.
Diabetes Research and Clinical Practice|December 23, 2008
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and KoreaViswanathan Mohan, Wenying Yang, Ho-Young Son, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1998
Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAMB D Holst, P W Vanderklish, L A Krushel, et al.
European Journal of Clinical Pharmacology|February 9, 2012
Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal diseaseTeddy Kosoglou, Walter K Kraft, Bharath Kumar, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Journal of the American Society of Hypertension : JASH|March 23, 2011
Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertensionSukrut Shah, Anne Hermanowski-Vosatka, Kendra Gibson, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
WITHDRAWN: Pelvic floor muscle training for urinary incontinence in womenE J C Hay-Smith, K Bø, L C M Berghmans, et al.
Pageof 11